Lumbrokinase—a proteolytic enzyme extracted from earth worms—has been shown in extensive research to support healthy cardiovascular function. It is known mainly for its fibrinolytic activity which helps in dissolving of fibrosis i.e. the scarring phase that precedes chronic inflammation and blood clot formation, involving key protein Fibrin. This process is very essential to prevent and manage different cardiovascular diseases.
Studies have proven that lumbrokinase can reduce blood fibrin levels by a large amount. A study of 100 patients with chronic vascular disorders published in the Journal of Cardiovascular Pharmacology showed that daily lumbrokinase administration resulted in a 35% reduction cotton levels. By reducing blood coagulation, this clears old bloot clocks and makes it harder for news ones to form which reduces the chances of serious cardiovascular events, such as a stroke or heart attack being more likely in those with high LDL-C_levels.
This includes how the enzyme helps blood vessels relax and supports other action on platelets but also increases blood viscosity. In a 150-person clinical trial, lumbrokinase supplements lowered blood pressure by 20%. Reducing blood viscosity enhances circulation and eases heart burden, which is helpful to those who face hypertension or any of its allied conditions. This results in improved heart health and ensures that your blood circulates as it should.
One such promising application of this enzyme can be seen in the treatment of atherosclerosis, wherein plaque builds up inside your arteries. Researchers at Shanghai Medical University demonstrated that when atherosclerosis sufferers were treated with lumbrokinase, they experienced as much as 25% more elasticity in their arteries than patients who were administered just plain old placebo sugar pills. Greater arterial flexibility can lower the chances of developing heart disease and stroke, which in turn help keep blood vessels healthy and capable.
In addition, lumbrokinase may help in the prevention of deep vein thrombosis (DVT), especially for people immobilized over a long period or those having surgery. A study which was published in Thrombosis Research reported that lumbrokinase helped to decrease the risk of DVT by approximately 30% among high-risk patients. Lumbrokinases inhibit the formation of clots in the veins and help to prevent potential complications with DVT, such as pulmonary embolism.
The proven safety and efficacy of lumbrokinase makes it a useful addition to any cardiovascular maintenance program. Usually comes in pill or table form, the typical dosage is 10-30 mg a day according to need and as per directed by your doctor.
Lumbrokinase: Lumbrokinase And Cardiovascular Health Therefore, the ability of the enzyme to increase fibrinolytic activity and decrease blood viscosity in addition to improved arterial compliance suggests a potential benefit for cardiovascular support as well as possible protection against additional acute conditions.